Cargando…
Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645523/ http://dx.doi.org/10.1186/2051-1426-3-S2-P108 |
| _version_ | 1782400831862079488 |
|---|---|
| author | Tada, Kohei Kitano, Shigehisa Shoji, Hirokazu Nishimura, Takashi Shimada, Yasuhiro Nagashima, Kengo Honma, Yoshitaka Iwasa, Satoru Okita, Natsuko Takashima, Atsuo Kato, Ken Yamada, Yasuhide Katayama, Naoyuki Boku, Narikazu Hamaguchi, Tetsuya Heike, Yuji |
| author_facet | Tada, Kohei Kitano, Shigehisa Shoji, Hirokazu Nishimura, Takashi Shimada, Yasuhiro Nagashima, Kengo Honma, Yoshitaka Iwasa, Satoru Okita, Natsuko Takashima, Atsuo Kato, Ken Yamada, Yasuhide Katayama, Naoyuki Boku, Narikazu Hamaguchi, Tetsuya Heike, Yuji |
| author_sort | Tada, Kohei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46455232015-11-20 Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy Tada, Kohei Kitano, Shigehisa Shoji, Hirokazu Nishimura, Takashi Shimada, Yasuhiro Nagashima, Kengo Honma, Yoshitaka Iwasa, Satoru Okita, Natsuko Takashima, Atsuo Kato, Ken Yamada, Yasuhide Katayama, Naoyuki Boku, Narikazu Hamaguchi, Tetsuya Heike, Yuji J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645523/ http://dx.doi.org/10.1186/2051-1426-3-S2-P108 Text en Copyright © 2015 Tada et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Tada, Kohei Kitano, Shigehisa Shoji, Hirokazu Nishimura, Takashi Shimada, Yasuhiro Nagashima, Kengo Honma, Yoshitaka Iwasa, Satoru Okita, Natsuko Takashima, Atsuo Kato, Ken Yamada, Yasuhide Katayama, Naoyuki Boku, Narikazu Hamaguchi, Tetsuya Heike, Yuji Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| title | Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| title_full | Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| title_fullStr | Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| title_full_unstemmed | Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| title_short | Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| title_sort | immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645523/ http://dx.doi.org/10.1186/2051-1426-3-S2-P108 |
| work_keys_str_mv | AT tadakohei immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT kitanoshigehisa immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT shojihirokazu immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT nishimuratakashi immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT shimadayasuhiro immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT nagashimakengo immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT honmayoshitaka immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT iwasasatoru immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT okitanatsuko immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT takashimaatsuo immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT katoken immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT yamadayasuhide immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT katayamanaoyuki immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT bokunarikazu immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT hamaguchitetsuya immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy AT heikeyuji immunestatusatpretreatmentimpactsonprogressionfreesurvivalofmetastaticcolorectalcancerpatientstreatedwithfirstlinechemotherapy |